38949-69-8Relevant academic research and scientific papers
Synthesis of aryloxyacetonitriles based on arylboronic acids with 2-bromoacetonitrile
Li, Yingmin,Guo, Mengping,Wen, Yongju,Zhou, Lanjiang,Shen, Xiuli,Kang, Yangping
supporting information, (2020/09/09)
A new and efficient protocol for the synthesis of aryloxyacetonitriles based on arylboronic acids with 2-bromoacetonitrile has been developed using eco-friendly hydrogen peroxide as oxidant under metal-free conditions. This method is compatible with arylboronic acid attached sensitive substituent and obtains desired product in moderate to good yield.
MODULATORS OF THE INTEGRATED STRESS PATHWAY
-
Page/Page column 139, (2019/05/22)
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
MODULATORS OF THE INTEGRATED STRESS PATHWAY
-
Page/Page column 134, (2017/12/13)
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
Effect of Methoxy Substitution on the Adrenergic Activity of Three Structurally Related α2-Adrenoreceptor Antagonists
Stillings, Michael R.,England, C. David,Welbourn, Anthony P.,Smith, Colin F. C.
, p. 1780 - 1783 (2007/10/02)
We have recently reported the synthesis and α2-antagonist activity of the methoxy derivative 2 and described the enhanced potency of this compound over the parent 1,4-benzodioxan, idazoxan, in
Composition and process for promoting the growth of crop plants
-
, (2008/06/13)
Compounds of the formula wherein Ar is (substituted) phenyl or naphthyl, X is oxygen, sulfur, SO or SO2, n is 1-3 and R is CN or C(NH2)NOR1, (wherein R1 is preferably hydrogen) are useful as safeners in crop protection.
Method of inhibiting sickling of sickle erythrocytes using substituted-2-imidazolines
-
, (2008/06/13)
Method for inhibiting the sickling of sickle erythrocytes in blood by contacting the sickle erythrocytes with a compound of the formula: STR1 or a pharmaceutically-acceptable salt thereof, wherein X represents sulfur, oxygen or imino; Rm represents chloro, bromo, fluoro or iodo; and Rp represents chloro, bromo, fluoro, iodo, hydroxy, amino or alkyl.
